During the past decade, Centrum Medyczne Pratia Poznań conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Pratia Poznań" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Pfizer" with 5 trials sponsored, "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "ADC Therapeutics S.A." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Poznań" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Poznań" are "Lymphoma, Non-Hodgkin" (5 trials), "Leukemia, Lymphocytic, Chronic, B-Cell" (4 trials), "Multiple Myeloma" (4 trials), "Lymphoma, Mantle-Cell" (3 trials) and "COVID-19 Prevention" (2 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Poznań" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Pratia Poznań" are "Drug" (31 trials), "Biological" (7 trials), "Combination Product" (2 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (5 trials), "Rituximab" (5 trials), "Placebo" (4 trials), "Elranatamab" (3 trials) and "Ibrutinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Pratia Poznań" are 36 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Medyczne Pratia Poznań". undefined are not yet recruiting, 24 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centrum Medyczne Pratia Poznań, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Pratia Poznań, 8 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".